Nandrolone hydrogen succinate
![]() | |
| Clinical data | |
|---|---|
| Trade names | Anabolico, Menidrabol |
| Other names | Nandrolone hemisuccinate; 19-Nortestosterone 17β-(3-carboxy)propionate |
| Routes of administration | Intramuscular injection |
| Drug class | Androgen; Anabolic steroid; Androgen ester; Progestogen |
| Identifiers | |
IUPAC name
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.027.136 |
| Chemical and physical data | |
| Formula | C22H30O5 |
| Molar mass | 374.477 g·mol−1 |
| 3D model (JSmol) | |
SMILES
| |
InChI
| |
Nandrolone hydrogen succinate (brand name Anabolico, Menidrabol), or nandrolone hemisuccinate, also known as 19-nortestosterone 17β-(3-carboxy)propionate, is a synthetic androgen and anabolic steroid and a nandrolone ester that is or has been marketed in Italy.[1][2][3][4][5]
| Compound | PR | AR | ER | GR | MR | SHBG | CBG |
|---|---|---|---|---|---|---|---|
| Nandrolone | 20 | 154–155 | <0.1 | 0.5 | 1.6 | 1–16 | 0.1 |
| Testosterone | 1.0–1.2 | 100 | <0.1 | 0.17 | 0.9 | 19–82 | 3–8 |
| Estradiol | 2.6 | 7.9 | 100 | 0.6 | 0.13 | 8.7–12 | <0.1 |
| Notes: Values are percentages (%). Reference ligands (100%) were progesterone for the PR, testosterone for the AR, estradiol for the ER, dexamethasone for the GR, aldosterone for the MR, dihydrotestosterone for SHBG, and cortisol for CBG. Sources: See template. | |||||||
See also
References
- ↑ Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 660–. ISBN 978-1-4757-2085-3.
- ↑ Index Nominum 2000: International Drug Directory. Taylor & Francis. January 2000. pp. 716–717. ISBN 978-3-88763-075-1.
- ↑ Morton IK, Hall JM (6 December 2012). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Science & Business Media. ISBN 978-94-011-4439-1.
- ↑ Krüskemper HL (22 October 2013). Anabolic Steroids. Elsevier. pp. 200–. ISBN 978-1-4832-6504-9.
- ↑ Kern W, List PH, Hörhammer L (29 July 2013). Hagers Handbuch der Pharmazeutischen Praxis: Für Apotheker, Arzneimittelhersteller, Ärzte und Medizinalbeamte: Wirkstoffgruppen II Chemikalien und Drogen (A-AL). Springer-Verlag. pp. 149–. ISBN 978-3-662-25655-8.
| Progestogens (and progestins) |
| ||||
|---|---|---|---|---|---|
| Antiprogestogens |
| ||||
| |||||
Androgen receptor modulators | |||||||
|---|---|---|---|---|---|---|---|
| AR |
| ||||||
| GPRC6A |
| ||||||
| |||||||
Progesterone receptor modulators | |||||||
|---|---|---|---|---|---|---|---|
| PR |
| ||||||
| mPR (PAQR) |
| ||||||
| |||||||
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.
